Biotech Values

[bladerunner1717]

Hey guys, you can trash GENR all you want, but they still have a Phase III with an SPA for a huge indication. And very close collaboration with the FDA. Whatever you want to criticize about them is fine, but this no scam outfit.

Frankly, I don't see why the naysayers sound so hysterical about GENR. Maybe they're right. But we're going to know pretty much what we need to know about the direction of the company in the next five months, so why not just watch and wait how this pans out.

By the way, Dew, I think Curis (CRIS) reports on Aug. 9.


Bladerunner